Your browser doesn't support javascript.
loading
Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue.
Kumar, Anita; Bantilan, K S; Jacob, A P; Park, A; Schoninger, S F; Sauter, C; Ulaner, G A; Casulo, C; Faham, M; Kong, K A; Grewal, R K; Gerecitano, J; Hamilton, A; Hamlin, P; Matasar, M; Moskowitz, C H; Noy, A; Palomba, M L; Portlock, C S; Younes, A; Willis, T; Zelenetz, A D.
Affiliation
  • Kumar A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: kumara2@mskcc.org.
  • Bantilan KS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Jacob AP; Adaptive Biotechnologies, Seattle, WA.
  • Park A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Schoninger SF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Sauter C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ulaner GA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Casulo C; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Faham M; Adaptive Biotechnologies, Seattle, WA.
  • Kong KA; Adaptive Biotechnologies, Seattle, WA.
  • Grewal RK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Gerecitano J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamilton A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamlin P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Matasar M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Noy A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Palomba ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Portlock CS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Younes A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Willis T; Adaptive Biotechnologies, Seattle, WA.
  • Zelenetz AD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Clin Lymphoma Myeloma Leuk ; 21(4): 230-237.e12, 2021 04.
Article de En | MEDLINE | ID: mdl-33558202
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: ADN tumoral / Lymphome à cellules du manteau / Récidive tumorale locale Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Clin Lymphoma Myeloma Leuk Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: ADN tumoral / Lymphome à cellules du manteau / Récidive tumorale locale Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Clin Lymphoma Myeloma Leuk Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article